Oyster Mushroom
Marketed as a natural source of lovastatin and beta-glucans for cholesterol. The two best-controlled human trials both failed to lower LDL or non-HDL cholesterol.
Evidence last reviewed: August 2026
What the science says
- LDL cholesterol Limited evidence
A double-blind randomised controlled trial in 46 adults with moderately elevated LDL gave 8.4 g/day of oyster mushroom powder (3 g beta-glucans) for 4 weeks and found no effect on LDL, other lipids or apolipoproteins. A post-hoc analysis suggested reduced cholesterol absorption markers in women only.
- Lipids in a clinical population Limited evidence
An open-label 8-week study in 20 HIV patients with antiretroviral-induced hyperlipidaemia found 15 g/day of freeze-dried Pleurotus ostreatus did not lower non-HDL cholesterol; only 3 of 20 achieved a clinically meaningful decline.
- Visceral fat and metabolic markers Limited evidence
A small community study in rural Mexico reported reductions in visceral fat and blood lipids with dietary oyster mushroom, but it was not a rigorous placebo-controlled design and stands against the two negative controlled trials.
Dosage & safety
Scientific references
- Effects of regular consumption of a β-glucan-rich oyster mushroom powder on cholesterol metabolism in adults with moderately elevated LDL-cholesterol concentrations: a double-blind randomized controlled trial
- Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy
- Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Heart & metabolic
- Vitamin B3 (Niacin) Limited evidence
- Vitamin K2 (MK-7) Limited evidence
- Chromium Limited evidence
- Potassium Strong evidence
- Vanadium Limited evidence
- L-Arginine Moderate evidence